[1] Barrett, E.S., Chen, C., Thurston, S.W., Haug, L.S., Sabaredzovic, A., Fjeldheim, F.N., et al. Perfluoroalkyl substances and ovarian hormone concentrations in naturally cycling women. Fertil Steril. 2015;103:1261-1270.
[2] Ramhoj, L., Hass, U., Boberg, J., Scholze, M., Christiansen, S., Nielsen, F., et al. Perfluorohexane Sulfonate (PFHxS) and a mixture of endocrine disrupters reduce thyroxine levels and cause antiandrogenic effects in rats. Toxicol Sci. 2018;163:579-591.
[3] Lau, C., Anitole, K., Hodes, C., Lai, D., Pfahles-Hutchens, A., Seed, J. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci. 2007; 99:366-394.
[4] Ali, J.M., Roberts, S.M., Gordon, D.S., Stuchal, L.D. Derivation of a chronic reference dose for perfluorohexane sulfonate (PFHxS) for reproductive toxicity in mice. Regul Toxicol Pharmacol. 2019;108:104452.
[5] Mamsen, L.S., Bjorvang, R.D., Mucs, D., Vinnars, M.T., Papadogiannakis, N., Lindh, C.H., et al. Concentrations of perfluoroalkyl substances (PFASs) in human embryonic and fetal organs from first, second, and third trimester pregnancies. Environ Int. 2019;124:482-492.
[6] Sundstrom, M., Chang, S.C., Noker, P.E., Gorman, G.S., Hart, J.A., Ehresman, D.J., et al. Comparative pharmacokinetics of perfluorohexanesulfonate (PFHxS) in rats, mice, and monkeys. Reprod Toxicol. 2012;33:441-451.
[7] Olsen, G.W., Burris, J.M., Ehresman, D.J., Froehlich, J.W., Seacat, A.M., Butenhoff, J.L., et al. Half-life of serum elimination of perfluorooctanesulfonate,perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ. Health Perspect. 2007;115:1298-1305.
[8] Mccoy, J.A., Bangma, J.T., Reiner, J.L., Bowden, J.A., Schnorr, J., Slowey, M., et al. Associations between perfluorinated alkyl acids in blood and ovarian follicular fluid and ovarian function in women undergoing assisted reproductive treatment. Sci Total Environ. 2017; 605-606:9-17.
[9] Li, Y., Cheng, Y., Xie, Z., Zeng, F. Perfluorinated alkyl substances in serum of the southern Chinese general population and potential impact on thyroid hormones. Sci Rep. 2017;7:43380.
[10] Kjeldsen, L.S., Bonefeld-Jorgensen, E.C. Perfluorinated compounds affect the function of sex hormone receptors. Environ Sci Pollut Res Int. 2013;20:8031-8044.
[11] Butenhoff, J.L., Chang, S.C., Ehresman, D.J., York, R.G. Evaluation of potential reproductive and developmental toxicity of potassium perfluorohexanesulfonate in Sprague Dawley rats. Reprod Toxicol. 2009;27:331-341.
[12] Gottsch, M.L., Cunningham, M.J., Smith, J.T., Popa S.M., Acohido, B.V., Crowley, W.F., et al. A role for kisspeptins in the regulation of gonadotropin secretion in the mouse. Endocrinology. 2004; 145:4073-4077.
[13] Adekunbi, D.A., Li, X.F., Li, S., Adegoke, O.A., Iranloye, B.O., Morakinyo, A.O., et al. Role of amygdala kisspeptin in pubertal timing in female rats. PLoS One. 2017;12:e183596.
[14] Pinilla, L., Aguilar, E., Dieguez, C., Millar, R.P., Tena-Sempere, M. Kisspeptins and reproduction: physiological roles and regulatory mechanisms. Physiol Rev. 2012;92:1235-1316.
[15] Han, S.K., Gottsch, M.L., Lee, K.J., Popa, S.M., Smith, J.T., Jakawich, S.K., et al. Activation of gonadotropin-releasing hormone neurons by kisspeptin as a neuroendocrine switch for the onset of puberty. J Neurosci. 2005; 25:11349-11356.
[16] Herbison, A.E., De Tassigny, X., Doran, J., Doran, J., Colledge, W.H. Distribution and postnatal development of Gpr54 gene expression in mouse brain and gonadotropin-releasing hormone neurons. Endocrinology. 2010;151:312-321.
[17] Irwig, M.S., Fraley, G.S., Smith, J.T., Acohido, B.V., Popa, S.M., Cunningham, M.J., et al. Kisspeptin activation of gonadotropin releasing hormone neurons and regulation of KiSS-1 mRNA in the male rat. Neuroendocrinology. 2004;80:264-272.
[18] Ohtaki, T., Shintani, Y., Honda, S., Hori, A., Kanehashi, K., Terao, Y., et al. Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. Nature. 2001;411:613-617.
[19] Brock, O., Bakker, J. The two kisspeptin neuronal populations are differentially organized and activated by estradiol in mice. Endocrinology. 2013;154:2739-2749.
[20] Ke, R., Ma, X., Lee, L. Understanding the functions of kisspeptin and kisspeptin receptor (Kiss1R) from clinical case studies. Peptides. 2019;120:170019.
[21] Li, Y., Fletcher, T., Mucs, D., Scott, K., Lindh, C.H., Tallving, P., et al. Half-lives of PFOS, PFHxS and PFOA after end of exposure to contaminated drinking water. Occup Environ Med. 2018;75: 46-51.
[22] Caligioni CS. Assessing reproductive status/stages in mice. Curr Protoc Neurosci Appendix. 2009; 4:4I.
[23] Diamanti-Kandarakis, E., Papalou, O., Kandaraki, E.A., Kassi, G. Mechanisms in endocrinology: Nutrition as a mediator of oxidative stress in metabolic and reproductive disorders in women. Eur J Endocrinol. 2017;176:R79-R99.
[24] Tan, R., He, Y., ZHANG, S., Pu, D., Wu, J. Effect of transcutaneous electrical acupoint stimulation on protecting against radiotherapy- induced ovarian damage in mice. J Ovarian Res. 2019;12: 65.
[25] Braun J.M. Early-life exposure to EDCs: role in childhood obesity and neurodevelopment. Nat Rev Endocrinol. 2017;13:161-173.
[26] Calafat, A.M., Wong, L.Y., Kuklenyik, Z., Reidy, J.A., Needham, L.L. Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ Health Perspect. 2007;115:1596-1602.
[27] Lindstrom, A.B., Strynar, M.J., Libelo, E.L. Polyfluorinated compounds: past, present, and future. Environ. Sci Technol. 2011;45:7954-7961.
[28] Zhang, S., Tan, R., Pan, R., Xiong, J., Tian, Y., Wu, J., et al. Association of Perfluoroalkyl and Polyfluoroalkyl Substances With Premature Ovarian Insufficiency in Chinese Women. J. Clin Endocrinol Metab. 2018;103:2543-2551.
[29] Zhou, W., Zhang, L., Tong, C., Fang, F., Zhao, S., Tian, Y., et al. Plasma perfluoroalkyl and polyfluoroalkyl substances concentration and menstrual cycle characteristics in preconception women. Environ Health Perspect. 2017;125:67012.
[30] Wolf, D.C., Moore, T., Abbott, B.D., Rosen, M.B., Das, K.P., Zehr, R.D., et al. Comparative hepatic effects of perfluorooctanoic acid and WY 14,643 in PPAR-alpha knockout and wild-type mice. Toxicol Pathol. 2008;36:632-639.
[31] Vabre, P., Gatimel, N., Moreau, J., Gayrard, V., Picard-Hagen, N., Parinaud, J., et al. Environmental pollutants, a possible etiology for premature ovarian insufficiency: a narrative review of animal and human data. Environ Health. 2017;16:37.
[32] Perez, F., Nadal, M., Navarro-Ortega, A., Fàbrega, F., Domingo, J.L., Barceló, D., et al. Accumulation of perfluoroalkyl substances in human tissues. Environ Int. 2013;59:354-362.
[33] Han, X., Nabb, D.L., Russell, M.H., Kennedy, G.L., Rickard, R.W. Renal elimination of perfluorocarboxylates (PFCAs). Chem Res Toxicol. 2012;25:35–46.
[34] Knox, S.S., Jackson, T., Javins, B., Frisbee, S.J., Shankar, A., Ducatman, A.M. Implications of early menopause in women exposed to perfluorocarbons. J Clin Endocrinol Metab. 2011;96:1747-1753.
[35] Preston, E.V., Webster, T.F., Oken, E., Claus Henn, B., McClean, M.D., Rifas-Shiman, S.L., et al. Maternal plasma per- and polyfluoroalkyl substance concentrations in early pregnancy and maternal and neonatal thyroid function in a prospective birth cohort: Project viva (USA). Environ Health Perspect. 2018;126:27013.
[36] Gleason, J.A., Post, G.B., Fagliano, J.A. Associations of perfluorinated chemical serum concentrations and biomarkers of liver function and uric acid in the US population (NHANES), 2007-2010. Environ Res. 2015;136: 8-14.
[37] Stein, C.R., Mcgovern, K.J., Pajak, A.M., Maglione, P.J., Wolff, M.S. Perfluoroalkyl and polyfluoroalkyl substances and indicators of immune function in children aged 12-19 y: National Health and Nutrition Examination Survey. Pediatr Res. 2016; 79:348-357.
[38] Maeda, K., Adachi, S., Inoue, K., Ohkura, S., Tsukamura, H. Metastin/kisspeptin and control of estrous cycle in rats. Rev Endocr Metab Disord. 2007;8:21-29.
[39] Cooper, R.L., Conn, P.M., Walker, R.F. Characterization of the LH surge in middle-aged female rats. Biol Reprod. 1980;23: 611-615.
[40] Matsuda, F., Ohkura, S., Magata, F., Munetomo, A., Chen, J., Sato, M., et al. Role of kisspeptin neurons as a GnRH surge generator: Comparative aspects in rodents and non-rodent mammals. J Obstet Gynaecol Res. 2019;45:2318-2329.
[41] Smith, J.T., Cunningham, M.J., Rissman, E.F., Clifton, D.K., Steiner, R.A. Regulation of Kiss1 gene expression in the brain of the female mouse. Endocrinology. 2005;146:3686-3692.
[42] Smith, J.T., Dungan, H.M., Stoll, E.A., Gottsch, M.L., Braun, R.E., Eacker, S.M., et al. Differential regulation of KiSS-1 mRNA expression by sex steroids in the brain of the male mouse. Endocrinology. 2005;146: 2976-2984.
[43] Hrabovszky, E., Ciofi, P., Vida, B., Horvath, M.C., Keller, E., Caraty, A., et al. The kisspeptin system of the human hypothalamus: sexual dimorphism and relationship with gonadotropin-releasing hormone and neurokinin B neurons. Eur J Neurosci. 2010;31:1984-1998.
[44] Navarro, V.M., Castellano, J.M., Fernandez-Fernandez, R., Tovar, S., Roa, J., Mayen, A., et al. Characterization of the potent luteinizing hormone-releasing activity of KiSS-1 peptide, the natural ligand of GPR54. Endocrinology. 2005;146:156-163.
[45] Chang, S., Butenhoff, J.L., Parker, G.A., Coder, P.S., Zitzow, J.D., Krisko, R.M., et al. Reproductive and developmental toxicity of potassium perfluorohexanesulfonate in CD-1 mice. Reprod Toxicol. 2018;78:150-168.
[46] Ballesteros, V., Costa, O., Iniguez, C., Fletcher, T., Ballester, F., Lopez-Espinosa, M. Exposure to perfluoroalkyl substances and thyroid function in pregnant women and children: A systematic review of epidemiologic studies. Environ Int. 2017;99:15-28.
[47] Boesen, S., Long, M., Wielsoe, M., Mustieles, V., Fernandez, M.F., et al. Exposure to Perflouroalkyl acids and foetal and maternal thyroid status: a review. Environ Health. 2020;19:107.
[48] Attanasio R. Association between perfluoroalkyl acids and liver function: Data on sex differences in adolescents. Data Brief. 2019;27:104618.
[49] Yang, J., Wang, H., Du, H., Fang, H., Han, M., Xu, L., et al. Serum perfluoroalkyl substances in relation to lipid metabolism in Chinese pregnant women. Chemosphere. 2020;128566.
[50] Kokay, I.C., Petersen, S.L., Grattan, D.R. Identification of prolactin-sensitive GABA and kisspeptin neurons in regions of the rat hypothalamus involved in the control of fertility. Endocrinology. 2011;152:526-535.
[51] Araujo-Lopes, R., Crampton, J.R., Aquino, N.S., Miranda, R.M., Kokay, I.C., Reis, A.M., et al. Prolactin regulates kisspeptin neurons in the arcuate nucleus to suppress LH secretion in female rats. Endocrinology. 2014;155:1010-1020.
[52] Feng, X., Wang, X., Cao, X., Xia, Y., Zhou, R., Chen, L. Chronic exposure of female mice to an environmental level of perfluorooctane sulfonate suppresses estrogen synthesis through reduced histone H3K14 acetylation of the StAR promoter leading to deficits in follicular development and ovulation. Toxicol Sci. 2015;148:368-379.